Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (9)
  • 2025 (37)
  • 2024 (45)
  • 2023 (74)
  • 2022 (56)
  • 2021 (39)
  • 2020 (11)
  • 2019 (7)
  • 2018 (1)
  • 2017 (2)

Subject

  • Drug Trafficking (4210)
  • Synthetic drugs (1141)
  • Guns/Weapons (1041)
  • OCDETF/Task Force (820)
  • Fake Pills (688)
  • Arrests/Convictions - Major (646)
  • Guilty Plea (559)
  • Seizures (Drugs/Property) (484)
  • Prescription Drugs (372)
  • Overdose (327)
  • Major Law Enforcement Operation (278)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (239)
  • Pharmaceuticals/Pharmacists/Physicians (228)
  • Money Laundering (218)
  • Gangs (202)
  • Outreach/Drug Prevention (189)
  • Fentanyl Awareness (167)
  • One Pill Can Kill (118)
  • HIDTA (105)
  • Press Conferences (69)
  • Narcoterrorism (55)
  • Prevention/Education - DEA websites GSAD, JTT etc (54)
  • Extraditions (52)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Fentanyl Free America (41)
  • Counterfeit Pills (39)
  • Asset Forfeiture (30)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Congressional Affairs (15)
  • Campaigns (14)
  • Terrorism (14)
  • Other (12)
  • Critical Incident (9)
  • Intergovernmental Affairs (9)
  • Cartel (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (254)
  • Red Ribbon (27)

Drug Name

  • Opioids (43)
  • Oxycodone (38)
  • Fentanyl (33)
  • Hydromorphone (16)
  • Synthetic Opioids (10)
  • Benzodiazepines (9)
  • Morphine (7)
  • Methamphetamine (6)
  • Amphetamines (4)
  • Cocaine (3)
  • Heroin (3)
  • Methadone (3)
  • Steroids (3)
  • Marijuana (Cannabis) (2)
  • Ketamine (1)
  • Marijuana Concentrates (1)

Field Division

  • New England (36)
  • Washington, DC (34)
  • Seattle (25)
  • New York (23)
  • Chicago (19)
  • Sede (19)
  • Houston (16)
  • Omaha (15)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (10)
  • El Paso (9)
  • New Orleans (8)
  • San Francisco (7)
  • St. Louis (7)
  • Dallas (5)
  • Rocky Mountain (5)
  • Phoenix (4)
  • San Diego (4)
  • Los Angeles (3)
  • Louisville (3)
  • Detroit (1)
Clear All Results
281 Results - Showing 231 to 240
PRESS RELEASE

Doctor Charged With Accepting Bribes in Exchange for Fentanyl

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and Acting U.S. Attorney for the District of New Jersey Rachael A. Honig announced a Monmouth County, New Jersey, doctor was charged today for his participation in a scheme to receive bribes...
PRESS RELEASE

Red Ribbon Week Education Reaches Thousands Across the Midwest

OMAHA, Neb. -- Investigators with the Drug Enforcement Administration (DEA) Omaha Division reached thousands of individuals with messages of drug prevention and safety during annual Red Ribbon Week celebrations that began October 23. In addition to in-person presentations, 15 landmarks across the five-state division were lit with red lights, three...
PRESS RELEASE

Ringleader and Members of Multi-State Anabolic Steroid Trafficking Network Sentenced

NORFOLK, Va. – Today, a Richmond man was the sixth and final defendant to be sentenced for his role in a multi-state anabolic steroid conspiracy that operated across the country. According to court documents, Clyde Edward Peele, 46, is one of six members of a trafficking network, led by Michael...
PRESS RELEASE

DEA Kicks Off Annual Red Ribbon Campaign

WASHINGTON – The United States Drug Enforcement Administration kicked off its annual Red Ribbon Campaign, the nation’s largest drug prevention effort, on October 23. “Learning about the dangers of drugs, and talking about this with family and friends, reduces drug use, drug misuse, and addiction—especially for young people,” said DEA...
PRESS RELEASE

Landmarks Across Five State DEA Division Light Red for Red Ribbon Week

OMAHA, Neb.– The Drug Enforcement Administration (DEA) is kicking off Red Ribbon Week, Saturday, October 23, with 15 landmarks across the five state Omaha Division lighting up red to recognize the nation’s oldest and largest drug misuse prevention awareness program. Red Ribbon Week began following the death of DEA Special...
PRESS RELEASE

Iconic Chicago Buildings to Light Up Red for DEA’s Red Ribbon Week

CHICAGO – As part of a pledge to live drug free, several iconic buildings visible along the Chicago skyline, including Willis Tower, Blue Cross Blue Shield Tower, Prudential Plaza and 875 North Michigan will illuminate red lighting and display messaging in support of Red Ribbon Week on Saturday, Oct. 23...
PRESS RELEASE

Red Ribbon Week Proclamation Promotes Drug Education in Iowa

OMAHA, Neb.– Iowa Governor Kim Reynolds signed a proclamation declaring October 23-31, Red Ribbon Week across the state, urging citizens to take note of the observance by committing to healthy drug-free lifestyles and participating in drug prevention activities. The Drug Enforcement Administration (DEA) Omaha Division partnered with Iowa’s Office of...
PRESS RELEASE

Red Ribbon Week Proclamation Promotes Drug Education in Nebraska

OMAHA, Neb.– Drug Enforcement Administration (DEA) Omaha Division Special Agent in Charge Justin C. King stressed the importance of drug education and prevention at a Red Ribbon Week proclamation signing ceremony attended by Nebraska Lt. Governor Mike Foley at the Capitol in Lincoln. Red Ribbon Week is the nation’s oldest...
PRESS RELEASE

National Health Care Fraud Enforcement Action Results in Charges Involving over $1.4 Billion in Alleged Losses

DALLAS – The Department of Justice announced today criminal charges against 138 defendants, including 42 doctors, nurses, and other licensed medical professionals, in 31 federal districts across the United States, for their alleged participation in various healthcare fraud schemes that resulted in approximately $1.4 billion in alleged losses. The charges...
PRESS RELEASE

Seattle Doctor Settles Allegations

SEATTLE – Dr. Gerald Lee, a Seattle physician, has agreed to pay $150,000 to resolve allegations that he violated the Controlled Substances Act and False Claims Act. Specifically, the United States alleges that from January 2016 to September 2017, Dr. Lee violated the Controlled Substances Act by writing 23 prescriptions...

Paginación

  • Primera página «
  • Anterior
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Current page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster